A Phase-1, 6-Month Open-Label, Dose-Ranging Pharmacokinetic Study in Stabilized Patients with Schizophrenia Following Risperidone Implant
- Type
- Retraction
- Notice date
- 1/15/2018 0:00
- Journal
- Psychopharmacology Bulletin
- Publisher
- Medworks Media
- Notice DOI
- unavailable
- Original paper DOI
- unavailable